Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Vitamin D Receptor Gene Polymorphism Influences Lipid Profile In Patients With Juvenile Idiopathic Arthritis

J. Bašić, J. Vojinović, T. Jevtović-Stoimenov, M. Despotović, G. Sušić, D. Lazarević, V. Milošević, M. Cvetković, D. Pavlović
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Vitamin D receptor (VDR) gene FokI (rs2228570) polymorphism was postulated to influence outcome of several inflammatory diseases. The aim of this study was to evaluate the influence of rs2228570 polymorphism on lipid profile and on outcome in patients with juvenile idiopathic arthritis (JIA) treated with etanercept. A total of 153 subjects (62 JIA patients and 91 controls) were screened for the rs2228570 using the PCR-RFLP method. Lipid profile (cholesterol, triacylglycerol, HDL-C, and LDL-C) was determined using standard biochemical analysis in controls, while in JIA patients, it was determined prior to and 12 months after anti-TNF (etanercept) therapy. Clinical outcome was assessed using the JIA—American College of Rheumatology (ACR) response criteria. There were significant differences in the distribution of genotypes (p = 0.024) and alleles (p = 0.006; OR = 2.222, 95% CI 1.136–4.348) of the rs2228570 between patients and controls. Etanercept treatment significantly increased HDL-C levels (p = 0.006) in JIA patients with FF genotype in comparison to baseline values. No significant differences were seen in JIA—ACR 30/50/70 responses at month 12 between FF and Ff/ff genotype carriers. This is the first study to demonstrate the protective effect of the VDR FokI FF genotype on lipid profile in JIA patients treated with etanercept. However, this has to be confirmed in a larger cohort of patients.
This paper references
Etanercept Improves Lipid Profile and Oxidative Stress Measures in Patients with Juvenile Idiopathic Arthritis
S. De Sanctis (2013)
Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia
E. Alexeeva (2017)
25-Hydroxyvitamin D levels and juvenile idiopathic arthritis: Is there an association with disease activity?
Christina F. Pelajo (2011)
International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.
R. Petty (2004)
Preliminary definition of improvement in juvenile arthritis.
E. Giannini (1997)
Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behçet's disease in Tunisians.
E. Karray (2012)
Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients.
B. Görtz (2003)
Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-α-308GG genotype
J. Bašić (2010)
Vitamin D and the immune sys
N Maruotti (2010)
Vitamin D and the Immune System
N. Maruotti (2010)
Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population
J. Reis (2009)
Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis
Y. Lee (2011)
Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
E. Chow (2014)
Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.
I. van Eijk (2009)
Polymorphic variants of antioxidative defense enzymes and their gene-gene epistatic interactions in systemic lupus erythematode patients
T. Jevtović Stoimenov (2017)
Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.
O. Andrukhova (2014)
A Vitamin D Receptor Gene Polymorphism in the Translation Initiation Codon: Effect on Protein Activity and Relation to Bone Mineral Density in Japanese Women
H. Arai (1997)
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
A. Naranjo (2008)
Determinants of Vitamin D Levels in Children, Adolescents, and Young Adults with Juvenile Idiopathic Arthritis
S. Stagi (2014)
Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis
G. Murdaca (2018)
Intravenous transfusion of endothelial progenitor cells that overexpress vitamin D receptor inhibits atherosclerosis in apoE-deficient mice.
W. Xiang (2016)
Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept
M. Halbig (2009)
The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB.
P. Jurutka (2000)
Vitamin D receptor agonists’ anti‐inflammatory properties
J. Vojinović (2014)
Vitamin D Prevents Hypoxia/Reoxygenation-Induced Blood-Brain Barrier Disruption via Vitamin D Receptor-Mediated NF-kB Signaling Pathways
Soonmi Won (2015)
Cytokine pathways and joint inflammation in rheumatoid arthritis.
E. Choy (2001)
Cardiovascular Health in Childhood: A Statement for Health Professionals From the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association
C. Williams (2002)
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
P. Quartier (2003)
Relationship between inflammatory markers, oxidant–antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis
L. Breda (2012)
Vitamin D—update for the pediatric rheumatologists
J. Vojinović (2015)
Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behchet’s disease in Tunisians. Joint Bone Spine 79(2):144–148
EF Karray (2012)
What is a case-control study?
T. Marshall (2004)
Association of disease activity and anti-rheumatic treatment in juvenile idiopathic arthritis with serum lipid profiles: a prospective study.
Chang-Ching Shen (2013)
How to manage rheumatoid arthritis according to classic biomarkers and polymorphisms?
K. Mowla (2017)
Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes
MA Pani (2000)
Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis.
L. Masi (2002)
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry
G. Horneff (2017)
Vitamin D Receptor Gene Polymorphisms in Serbian Patients With Bronchial Asthma: A Case‐Control Study
M. Despotović (2017)
Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus
M. Cutolo (2009)
Lipid Profiles Alter from Pro-Atherogenic into Less Atherogenic and Proinflammatory in Juvenile Idiopathic Arthritis Patients Responding to Anti TNF-α Treatment
K. Yeh (2014)
Vitamin D in systemic lupus erythematosus
D. Kamen (2008)
Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans.
M. Pani (2000)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar